Bonum Names Samuel Blackman to Board of Directors
03 Dec 2024 //
BUSINESSWIRE
Bonum to Present Conditionally Activated Therapy Platform
29 Apr 2024 //
BUSINESSWIRE
Bonum Therapeutics to Present Poster on Lead Program at AACR 2024
05 Mar 2024 //
BUSINESSWIRE
Roche-backed Bonum bags $93M series A
15 Nov 2022 //
FIERCEBIOTECH
Bonum Therapeutics Announces a $93M Series A Financing
15 Nov 2022 //
BUSINESSWIRE